RYTM FY 2017 Earnings — Rhythm Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RYTMRhythm Pharmaceuticals, Inc.

$6B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$223,000

Operating Income

-$32M

Net Income

-$34M

EPS (Diluted)

$-1.26

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$30M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$152M

Total Liabilities

$7M

Stockholders' Equity

$145M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$223,000	-$144,000	-54.9%
Operating Income	-$32M	-$26M	-25.1%
Net Income	-$34M	-$26M	-30.3%